Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines April 17, 2015

News: Army extends benefits to Hood shooting victims¬†- The Army will provide “all possible benefits” to victims of the 2009 Fort Hood shooting who recently were awarded the Purple Heart, the service announced April 16.   Business: Rolls-Royce lands biggest deal in its 109-year history¬†- U.K. engineering company Rolls-Royce has won the largest order in...
 
 

News Briefs April 17, 2015

Army orders financial benefits for 2009 Fort Hood victims Dozens of soldiers and surviving family members of the 2009 Fort Hood, Texas, shooting are receiving additional Army pay that they felt was long overdue. The announcement from Army Sec. John McHugh April 16 comes a week after 36 Purple Hearts were awarded to victims and...
 
 
NASA illustration

NASA awards radiation challenge winners, launches next round

NASA illustration This illustration depicts our heliosphere, showing the approximate locations of Voyager 1 and Voyager 2 spacecraft. Galactic cosmic rays originate outside the heliosphere and stream in uniformly from all direc...
 

 

U.S. Air Force completes operational testing on Raytheon’s MALD-J

Raytheon and the U.S. Air Force successfully completed operational tests of Miniature Air Launched Decoy-Jammer, satisfying all requirements to attain Initial Operational Capability. “MALD-J’s unique capabilities have been proven in 42 successful flight tests during the last two years and brought us closer to full rate production,” said Mike Jarrett, vice president of Raytheon...
 
 

Northrop Grumman to expand North Dakota presence

In partnership with local leadership, Northrop Grumman confirmed its dedication to the future of unmanned systems development in the Red River Valley region by signing a lease agreement to anchor the new Grand Sky Technology Park in Grand Forks County. Northrop Grumman is working to identify specialized opportunities for the Grand Sky facility. The opportunities,...
 
 

Raytheon awarded more than $2 billion for an International Patriot system

Raytheon announced April 17 it has been awarded a contract worth over $2.0 billion to deliver the combat-proven Patriot Air and Missile Defense System to an undisclosed international customer. The contract, awarded April 2, 2015, and booked in the second quarter as a direct commercial sale, includes fully digitized new-production Patriot fire units with the...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>